[1]
|
McWhinney, P.H., Kibbler, C.C., Gillespie, S.H., Patel, S., Morrison, D., Hoffbrand, A.V. and Prentice, H.G. (1992) Stomatococcusmucilaginosus: An emerging pathogen in neutropenic patients. Clinical Infectious Diseases, 14, 641-646. doi:10.1093/clinids/14.3.641
|
[2]
|
Henwick, S., Koehler, M. and Patrick, C.C. (1993) Complications of bacteremia due to Stomatococcusmucilaginosus in neutropenic children. Clinical Infectious Diseases, 17, 667-671. doi:10.1093/clinids/17.4.667
|
[3]
|
Gruson, D., Hilbert, G., Pigneux, A., Vargas, F., Guisset, O., Texier, J., Boiron, J.M., Reiffers, J., Gbikpi-Benissan, G. and Cardinaud, J.P. (1998) Severe infection caused by Stomatococcusmucilaginosus in a neutropenic patient: case report and review of the literature. Hematology and Cell Therapy, 40, 167-169.
|
[4]
|
Van Tiel, F.H., Slangen, B.F., Schouten, H.C. and Jacobs, J.A. (1995) Study of Stomatococcusmucilaginosusiso lated in a hospital ward using phenotypic characterization. European Journal of Clinical Microbiology and Infectious Diseases, 14, 193-198. doi:10.1007/BF02310355
|
[5]
|
Lee, A.B., Harkery-Murray, P., Ferrieri, P., Schleiss, M.R. and Tolar, J. (2008) Bacterial meningitis from rothiamu-cilaginosa in patients with malignancy or undergoing hematopoietic stem cell transplantation. Pediatric Blood Cancer, 50, 673-676. doi:10.1002/pbc.21286
|
[6]
|
Mitchell, P.S., Huston, B.J., Jones, R.N., Holcomb, L. and Koontz, F.P. (1990) Stomatococcusmucilaginosusbacteraemias: Typical case presentations, simplified diagnostic criteria, and a literature review. Diagnostic Microbiology and Infectious Disease, 13, 521-525.
doi:10.1016/0732-8893(90)90085-A
|
[7]
|
Goldman, M., Chaudhary, U.B., Greist, A. and Fausel, C.A. (1998) Central nervous system infections due to Stomatococcusmucilaginosus in immunocompromised hosts. Clinical Infectious Diseases, 27, 1241-1246.
doi:10.1086/515001
|
[8]
|
Relrnan, D.A., Ruoff, K., Ferraro, M.J. (1987) Stomato- coccusmucilaginosusendocarditis in an intravenous drugabuser. Journal of Infectious Diseases, 155, 1080-1082.
doi:10.1093/infdis/155.5.1080
|
[9]
|
Coudron, P.E., Markowitz, S.M., Mohanty, L.B., Schatzki, P.F., Payne, J.M. (1987) Isolation of Stomatococcu-smucilaginosusfrom a drug user with endocarditis. Journal of Clinical Microbiology, 25, 1359-1363.
|
[10]
|
Pinsky, R.L., Piscitelli, V. and Patterson, J.E. (1989) Endocarditis caused by relatively penicillin-resistant Stoma-tococcusmucilaginosus. Journal of Clinical Microbiology, 27, 215-221.
|
[11]
|
Rubin, S.J., Lyons, R.W. and Murcia, A. J. (1978) Endocarditis associated with cardiac catheterization due to a gram-positive coccus designated Micrococcus mucila- ginosusincertaesedis. Journal of Clinical Microbiology, 7, 546-549.
|
[12]
|
Schaad, U.B., Nelson, J.D., McCracken, G.H. Jr. (1981) Pharmacology and efficacy of vancomycin for staphylo-coccal infections in children. Rev Infect Dis., 3, S282- S288.
|
[13]
|
Luer, M.S. and Hatton, J. (1993) Vancomycin administration into the cerebrospinal fluid: A review. Annals of Pharmacotherapy, 27, 912-921.
|
[14]
|
Skogen, P.G., Kolmannskog, S. and Bergh, K. (2001) Bactericidal activity in cerebrospinal fluid by treating meningitis caused by Stomatococcusmucilaginosus with rifampicin, cefotaxime and vancomycin in a neutropenic child. Clinical Microbiology and Infection, 7, 39-42.
doi:10.1046/j.1469-0691.2001.00182.x
|
[15]
|
Von Eiff, C., Herman, M. and Peters, G. (1995) Antimicrobial susceptibilties of stomatococcus Mucilaginosa and of Micrococcus spp. Antimicrobial Agents and Chemotherapy, 39, 268-270.
|
[16]
|
Kaiser, A.B. and McGee, Z.A. (1975) Aminoglycoside therapy of gram-negative bacillary meningitis. New Eng- land Journal of Medicine, 293, 1215-1220.
doi:10.1056/NEJM197512112932401
|